Rifaximin 400 mg and Metronidazole 400 mg Tablets for Gastrointestinal Pharmaceutical Business
Chemsroot Pharmaceutical offers RIFAROOT M Tablet containing Rifaximin 400 mg and Metronidazole 400 mg in tablet form for pharmaceutical distribution and suitable B2B business opportunities.
RIFAROOT M can be considered by pharmaceutical distributors, PCD Pharma Franchise partners, pharma marketing companies and businesses looking for Pharmaceutical Third Party Manufacturing opportunities in the gastro and intestinal care segment.
The product artwork shared for RIFAROOT M shows the following key details:
- Brand Name RIFAROOT M Tablet
- Composition Rifaximin 400 mg plus Metronidazole 400 mg
- Dosage Form Film Coated Tablet
- Pack Size 10 x 10 Tablets
- MRP Rs 380 per strip
- GST 5 percent
The composition is positioned within the gastrointestinal category and may be relevant for pharmaceutical marketers who want to strengthen their gastro medicine portfolio with a combination formulation.
Composition of RIFAROOT M Tablet
Each film coated tablet contains:
- Rifaximin 400 mg
- Metronidazole 400 mg
- Excipients q s
RIFAROOT M combines two antimicrobial ingredients in a single tablet formulation.
The exact medical use, dosage, treatment duration, contraindications and precautions should always follow approved prescribing information and the advice of a qualified healthcare professional.
About Rifaximin 400 mg
Rifaximin is an antimicrobial medicine that is commonly associated with gastrointestinal therapy.
It acts locally within the gastrointestinal tract because systemic absorption is limited compared with many conventional antibiotics.
Rifaximin based products are generally prescribed by healthcare professionals for specific intestinal conditions depending on the patient and approved indication.
For pharmaceutical marketers, Rifaximin based products can form an important part of a gastro focused product portfolio.
About Metronidazole 400 mg
Metronidazole is an antimicrobial and antiprotozoal medicine widely used under medical supervision for susceptible infections.
In gastrointestinal pharmaceutical portfolios, Metronidazole is often included where anaerobic organisms or protozoal infections are relevant to approved clinical use.
The combination of Rifaximin and Metronidazole should be marketed responsibly and only according to approved product information.
Why Rifaximin 400 mg plus Metronidazole 400 mg Is Important for Pharma Marketers
Pharmaceutical distributors and marketers generally look for products that can strengthen their therapeutic range and provide a more complete gastro portfolio.
RIFAROOT M can be considered alongside other gastro products for professional pharmaceutical marketing where the composition is commercially and clinically relevant.
The product may be of interest to businesses working in:
- Gastro PCD Pharma Franchise
- Pharmaceutical Third Party Manufacturing
- Gastro Medicine Distribution
- Pharma Contract Manufacturing
- Own Brand Pharmaceutical Marketing
- Medicine Franchise Business
- Gastro Product Manufacturing
- Pharmaceutical Wholesale Distribution
Instead of building a product list based only on quantity, pharma businesses should evaluate whether each composition is relevant to the doctors, retailers and healthcare markets they serve.
Rifaximin Metronidazole Pharmaceutical Third Party Manufacturing
Chemsroot Pharmaceutical supports enquiries for Pharmaceutical Third Party Manufacturing for suitable formulations.
Businesses looking for Rifaximin 400 mg plus Metronidazole 400 mg Third Party Manufacturing can discuss their project requirements with Chemsroot Pharmaceutical.
Third Party Manufacturing allows pharmaceutical marketers to develop products under their own approved brand while manufacturing is coordinated through an appropriate manufacturing arrangement.
A typical project may involve:
- Composition confirmation
- Product feasibility check
- Brand name discussion
- Pack size finalization
- Artwork preparation
- Commercial approval
- Manufacturing coordination
- Quality documentation
- Packaging
- Dispatch planning
For a meaningful manufacturing quotation, pharma marketers should provide complete project details rather than only asking for price.
Information Required for Third Party Manufacturing
Businesses interested in Rifaximin Metronidazole Third Party Manufacturing should ideally provide:
- Required composition
- Preferred pack size
- Required quantity
- Proposed brand name
- Target market
- Delivery location
- Artwork requirement
- Expected order timeline
Providing this information helps the Chemsroot Pharmaceutical team understand the requirement more accurately.
RIFAROOT M PCD Pharma Franchise Opportunity
Chemsroot Pharmaceutical also works with pharmaceutical professionals and distributors exploring PCD Pharma Franchise opportunities.
RIFAROOT M Tablet can be considered as part of a suitable gastro product range depending upon current product availability and company commercial policy.
A PCD Pharma Franchise model may be useful for:
- Pharmaceutical distributors
- Pharma wholesalers
- Medical representatives starting their own business
- Existing PCD franchise holders
- Gastro product distributors
- Pharma marketing professionals
- Territory based medicine distributors
PCD Pharma Franchise availability may vary according to territory and product availability.
Interested partners should provide their preferred location and business details for a more relevant discussion.
Why Gastro PCD Pharma Franchise Can Be a Focused Business Segment
Gastrointestinal products form an important therapeutic category in pharmaceutical distribution.
A well planned gastro portfolio may include different dosage forms and compositions according to local market requirements.
Possible portfolio categories may include:
- Gastro tablets
- Suspensions
- Digestive enzyme products
- Anti infective products
- Acid management products
- Liver and intestinal care products
- Gastro capsules
RIFAROOT M can be positioned within such a portfolio where appropriate and permitted.
Packaging of RIFAROOT M Tablet
The shared product artwork shows RIFAROOT M in a 10 x 10 tablet pack.
The visual pack presentation includes:
- Outer printed carton
- Tablet strip presentation
- Brand identity RIFAROOT M
- Composition clearly displayed
- Gastrointestinal visual element
For Third Party Manufacturing projects, alternative packaging or brand presentation may be discussed depending upon manufacturing feasibility and commercial requirements.
Any packaging development should follow applicable pharmaceutical labeling requirements.
Benefits of Professional Pharmaceutical Third Party Manufacturing:
Third Party Manufacturing allows pharmaceutical marketers to focus more strongly on:
- Sales
- Distribution
- Customer relationships
- Brand development
- Customer relationships
- Territory expansion
- Marketing communication
while production is coordinated through an appropriate manufacturing arrangement.
This business model can reduce the need for substantial capital investment in independent manufacturing infrastructure.
However, marketers should carefully evaluate:
- Manufacturing capability
- Product documentation
- Label accuracy
- Commercial quantity
- Production timeline
- Supply planning
- Packaging quality
- Communication
before finalizing a manufacturing partner.
Why Choose Chemsroot Pharmaceutical
Chemsroot Pharmaceutical works with pharmaceutical distributors, marketing companies and business partners interested in PCD Pharma Franchise and Pharmaceutical Third Party Manufacturing.
The company focuses on professional B2B communication and coordinated product support.
Chemsroot Pharmaceutical works with pharmaceutical distributors, marketing companies and business partners interested in PCD Pharma Franchise and Pharmaceutical Third Party Manufacturing.
The company focuses on professional B2B communication and coordinated product support.
Business partners can discuss:
- Product availability
- PCD Pharma Franchise
- Third Party Manufacturing
- Brand development
- Packaging requirements
- Commercial quantities
- Order planning
- Product documentation
- Dispatch coordination
The objective is to develop sustainable pharma business relationships rather than one time transactions.
Who Can Enquire for RIFAROOT M Tablet
RIFAROOT M may be relevant for:
- Pharma marketing companies
- PCD Pharma Franchise distributors
- Gastro medicine distributors
- Pharmaceutical wholesalers
- Medicine retailers with distribution operations
- Pharma startups
- Brand owners
- Third Party Manufacturing buyers
- Medical representatives entering business
The exact business model should be chosen according to market knowledge, investment capacity, territory and business objectives.
Rifaximin Metronidazole Tablet Manufacturer in India
Businesses searching for a Rifaximin 400 mg plus Metronidazole 400 mg Tablet Manufacturer in India are often looking for either own brand manufacturing or an existing brand distribution opportunity.
Chemsroot Pharmaceutical can support suitable B2B discussions for both models.
For own brand requirements, businesses can explore Pharmaceutical Third Party Manufacturing.
For distribution of existing products such as RIFAROOT M, businesses can enquire about PCD Pharma Franchise availability.
Frequently Asked Questions
What is RIFAROOT M Tablet
RIFAROOT M is a film coated tablet containing Rifaximin 400 mg and Metronidazole 400 mg.
What is the pack size of RIFAROOT M
The product artwork provided shows a pack size of 10 x 10 tablets.
Is RIFAROOT M available for PCD Pharma Franchise
Suitable PCD Pharma Franchise opportunities can be discussed with Chemsroot Pharmaceutical depending on product and territory availability.
Is Rifaximin Metronidazole available for Third Party Manufacturing
Businesses can discuss Pharmaceutical Third Party Manufacturing requirements for the composition with Chemsroot Pharmaceutical. Manufacturing feasibility, quantity, packing and commercial terms should be confirmed for the specific project.
Can I manufacture Rifaximin Metronidazole under my own brand
Own brand manufacturing can be discussed under a suitable Third Party Manufacturing arrangement subject to applicable requirements and final manufacturing feasibility.
What details should I send for a quotation
Share:
- Composition
- Quantity
- Pack size
- Brand name
- Location
- Third Party Manufacturing or PCD requirement
This will help the team understand your enquiry faster.
Conclusion
RIFAROOT M Tablet combines Rifaximin 400 mg and Metronidazole 400 mg in a film coated tablet and is positioned within the gastrointestinal pharmaceutical segment.
Chemsroot Pharmaceutical supports pharmaceutical businesses looking for PCD Pharma Franchise and Pharmaceutical Third Party Manufacturing opportunities.
Businesses searching for a Rifaximin 400 mg plus Metronidazole 400 mg Tablet Manufacturer in India, Gastro PCD Pharma Franchise, Gastro Third Party Manufacturing or pharma contract manufacturing can contact Chemsroot Pharmaceutical with their exact requirements.
For faster B2B assistance, share your:
- Location
- Required quantity
- Preferred pack size
- Business experience
- Brand requirement
- PCD Pharma Franchise or Third Party Manufacturing requirement
Chemsroot Pharmaceutical can then provide more relevant product and commercial information for your business.
Keywords
